American College of Cardiology

  1. New heart guidelines a cash grab for statins

    Big Pharma lapdogs trying to force statins on millions

    You need two things to practice medicine as long as I did -- a steady hand and an iron stomach.

    When I bandaged war wounds as a flight surgeon, my hand never flinched. When I manned African clinics, treating tribesmen with viruses eating away their flesh, I never batted an eye.

    But for the first time in my 60 years of medicine, I can admit that I'm truly sickened -- and you should be, too. There's a cancerous epidemic sweeping across America today, threatening every man, woman and child from Anchorage to the Gulf Coast.

    But you won't read about it in any medical journal, and you won't find Tom Brokaw crowing about it on the evening news.

    Because this cancer, this disease, is political corruption, and it's spreading from shady backrooms in Washington where politicians are selling your health for pennies on the dollar.

    If you need proof just check out the new federal heart health guidelines that are designed to get every adult in America to start popping dangerous, cholesterol-lowering statins.

    You see, when our government decided we needed new heart health guidelines written, they didn't approach university scientists or create a panel of leading cardiologists. They handed the job -- lock, stock and barrel -- over to the American Heart Association and the American College of Cardiology, two organizations that have spent DECADES taking Big Pharma's cash in the form of "donations."

    Want to guess what happened? The crooks at the AHA and ACC have just released guidelines that will be used by thousands of physicians nationwide to put BILLIONS in drug company coffers -- and some of you into your graves.

    Under the new guidelines, half of all Americans over the age of 40 (and nearly all adults 60 and older) now qualify for statins. Drug companies will now be able to sell statins, which have been linked to liver disease and breast cancer, to an additional 13 million Americans a year. That's equivalent to the entire population of Pennsylvania.

    And aside from making drug company billionaires even richer, there's not a reason in the world for it. You see, the feds whine about a heart disease epidemic in America, but according to their own data heart disease has been the leading killer in America since AT LEAST 1935.

    Nothing has changed, except we now have billion-dollar drugs on the market, and a government that's willing to play ball.

    It's corruption that would have made Al Capone's mouth water, and you want no part of it. So at your next check-up, when your doc hits you with the "good news" that you now qualify for statins, tell him you have some news of your own.

    Your health isn't for sale.

  2. The mafia approach

    How Big Pharma buys guidelines

    It's the easiest billion dollars in the world: First, you invent a drug no one needs.

    Then, you buy off a panel of "experts" to convince the world that EVERYONE needs your drug.

    And no, this isn't some wild conspiracy theory. A recent study from the Archives of Internal Medicine proves (once again) that Big Pharma buys guideline panels the same way that the mafia buys juries.

    Researchers looked at 17 major guidelines created by the American Heart Association and American College of Cardiology between 2003 and 2008.

    These are guidelines used by docs, insurance companies, and even the government. But don't expect them to be fair and balanced. As it turns out, 56 percent of the 498 doctors and experts who wrote those guidelines had financial conflicts of interest.

    And if you think that's bad, wait until you see this: They also found that 81 percent of the leaders of the guideline-writing panels had a personal financial stake in the companies that would be impacted by those guidelines.

    It's an absolute disgrace, but it's not exactly news -- I've told you about this little scam for years.

    When it mattered most, the mainstream was silent... and now that all the major guidelines have already been signed, sealed and delivered, they're finally speaking up.

    Talk about too little, too late!

    And speaking of little and late, both the AHA and ACC are engaged in shoddy after-the-fact window-dressing: They say they've changed the rules, and that panel leaders must now be conflict-free, along with a majority of each panel.

    C'mon, this isn't rocket science -- there's one simple way to ensure conflict-free guidelines: Just don't let anyone with a conflict on the panel, period.

    There. Was that so hard?

    Then, commission these conflict-free panels to start from scratch and rewrite all the guidelines.

    But neither the AHA or ACC will consider that, and I'll bet it has something to do with their own conflicts: Both organizations rake in millions of dollars a year from Big Pharma.

    No matter how you look at it, the deck is stacked -- and you're on the losing side.

2 Item(s)